Related references
Note: Only part of the references are listed.SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults
Supinda Bunyavanich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong et al.
PEDIATRICS (2020)
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Urszula Radzikowska et al.
ALLERGY (2020)
Age and sex differences in soluble ACE2 may give insights for COVID-19
Per Sward et al.
CRITICAL CARE (2020)
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease
Patrick M. Brunner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2008)
Share Paper
